IL17A and experimental autoimmune encephalomyelitis: The administration of E2 at similar concentrations as in pregnancy increased the number of regulatory T cells, reduced IL-17 production, and protected from experimental autoimmune encephalomyelitis, in an animal model of multiple sclerosis75.